Cargando…
The proteome and phosphoproteome of circulating extracellular vesicle-enriched preparations are associated with characteristic clinical features in type 1 diabetes
INTRODUCTION: There are no validated clinical or laboratory biomarkers to identify and differentiate endotypes of type 1 diabetes (T1D) or the risk of progression to chronic complications. Extracellular vesicles (EVs) have been studied as biomarkers in several different disease states but have not b...
Autores principales: | Casu, Anna, Nunez Lopez, Yury O., Yu, Gongxin, Clifford, Christopher, Bilal, Anika, Petrilli, Alejandra M., Cornnell, Heather, Carnero, Elvis Alvarez, Bhatheja, Ananya, Corbin, Karen D., Iliuk, Anton, Maahs, David M., Pratley, Richard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417723/ https://www.ncbi.nlm.nih.gov/pubmed/37576973 http://dx.doi.org/10.3389/fendo.2023.1219293 |
Ejemplares similares
-
Proteomics and Phosphoproteomics of Circulating Extracellular Vesicles Provide New Insights into Diabetes Pathobiology
por: Nunez Lopez, Yury O., et al.
Publicado: (2022) -
Extracellular vesicle proteomics and phosphoproteomics identify pathways for increased risk in patients hospitalized with COVID-19 and type 2 diabetes mellitus
por: Nunez Lopez, Yury O., et al.
Publicado: (2023) -
Coordinated regulation of gene expression and microRNA changes in adipose tissue and circulating extracellular vesicles in response to pioglitazone treatment in humans with type 2 diabetes
por: Nunez Lopez, Yury O., et al.
Publicado: (2022) -
Investigation of Extracellular Vesicles From SARS-CoV-2 Infected Specimens: A Safety Perspective
por: Nunez Lopez, Yury O., et al.
Publicado: (2021) -
Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease
por: Hadisurya, Marco, et al.
Publicado: (2023)